Norepinephrineaspirologo (Norepinephrineaspirologo)
Norepinephrine Bitartrate Injection, Solution, Concentrate
Product Images NDC 31722-372
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Norepinephrine Bitartrate (NDC 31722-372). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Norepinephrinecartonlabel (Norepinephrinecartonlabel)
Norepinephrinecontainerlabel (Norepinephrinecontainerlabel)
This is a description of Norepinephrine Bitartrate Injection, USP, which is a medication with a concentration of 4 mg/4 mL (1 mg/mL) used for intravenous infusion only. The warning on the label mentions the presence of sulfites. Each mL contains norepinephrine bitartrate, USP equal to 1 mg. The vial is a 4 mL single-dose vial and should be diluted before use, with the unused portion to be discarded. The medication should be protected from light and has an expiration date (MM/YYYY) provided. Manufactured by Aspiro Pharma Limited in India for Camber Pharmaceuticals, Inc., with manufacturing license number 36/MD/AP2013/FI6 in Piscataway, NJ 08854.*
Norepinephrinestructure (Norepinephrinestructure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
